2) To phenotypically characterize multi-drug-resistant Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, proteus species, Citrobacter species, Salmonella and Shigella isolated ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

Scientists at Cincinnati Children's along with an international team of researchers have discovered a surprising new ...

The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...

anaerobic gram-positive cocci, and Fusobacterium species. The presence of these bacteria is only "normal" if the titer of resident flora is low. When bacterial titers exceed 1000 colony forming ...

Diluted EPS of $0.72 on a GAAP Basis, a Decrease of 6.5 Percent; Adjusted Diluted EPS of $2.46, an Increase of 6.5 Percent; These Results Include ...

TAXIS Pharmaceuticals, a clinical stage company at the forefront of developing therapies to treat multidrug-resistant bacterial infections and combat antimicrobial resistance (AMR), announced today ...

A compelling naturopathic case study by Dr. Eric Dorninger reveals how endotoxin exposure from kitty litter led to CIRS and ...

“Until now, no research has so vividly demonstrated treatment success of mastitis infections caused by Gram-negative bacteria like E. coli,” says Roger Saltman, DVM, MBA, Group Director, Pfizer Animal ...

Researchers are developing the biomaterial as a more environmentally friendly alternative to concrete, but any wide-scale use ...